• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Down 0.10%

    Portola Pharmaceuticals, Inc. (PTLA)

    -NasdaqGS
    39.80 Down 0.21(0.52%) 10:41AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:40.01
    Open:39.77
    Bid:39.66 x 100
    Ask:39.79 x 100
    1y Target Est:51.75
    Beta:0.747
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:39.12 - 39.94
    52wk Range:20.24 - 43.63
    Volume:52,965
    Avg Vol (3m):415,688
    Market Cap:2.07B
    P/E (ttm):N/A
    EPS (ttm):-3.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTLA

    Comparison

    Symbol% ChgMkt Cap
    PTLADown 0.52%2.07B
    BAYRYDown 0.19%N/A
    PFEDown 0.20%212.38B
    SNYUp 1.08%130.28B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):216.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.43
    Quarterly EPS Est (Jun-15) :-1.07
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback